GUIDED THERAPEUTICS, INC. (GTHP)

Every figure this model derived for GTHP, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 2,000 PaymentsToAcquirePropertyPlantAndEquipment 2025-12-31
cash 12,000 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 527,000 AssetsCurrent 2026-06-30
current liabilities 6,169,000 LiabilitiesCurrent 2026-06-30
equity -5,763,000 StockholdersEquity 2026-06-30
interest expense 600,000 InterestExpense 2026-06-30
ocf -1,504,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 650,000 Revenues 2026-06-30
sbc 126,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up GTHP on one particular measure came for.

RatioValue
cash operating margin-283.08
current ratio0.09
current ratio reported0.09
deferred revenue growth-72.16
dilution pct36.78
fcf margin-231.69
growth cv1.9
interest cover-3.29
operating margin-303.85
owner earnings margin-251.08
revenue growth450.85
revenue growth per share302.71
rpo growth-74.74
rule of 40147.0
sbc pct revenue19.38

What to be careful about

What this model itself distrusts about GTHP's figures. Written by the derivation as it ran, not added afterwards.